BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 8620609)

  • 1. Altered ventricular and myocyte response to angiotensin II in pacing-induced heart failure.
    Cheng CP; Suzuki M; Ohte N; Ohno M; Wang ZM; Little WC
    Circ Res; 1996 May; 78(5):880-92. PubMed ID: 8620609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II subtype-1 receptor blockade during the development of left ventricular hypertrophy in dogs: effects on ventricular and myocyte function.
    Spinale FG; Holzgrefe HH; Walker JD; Mukherjee R; Kribbs SB; Powell JR; Antonaccio M
    J Cardiovasc Pharmacol; 1997 Nov; 30(5):623-31. PubMed ID: 9388045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of ANG II and endothelin-1 in exercise-induced diastolic dysfunction in heart failure.
    Cheng CP; Ukai T; Onishi K; Ohte N; Suzuki M; Zhang ZS; Cheng HJ; Tachibana H; Igawa A; Little WC
    Am J Physiol Heart Circ Physiol; 2001 Apr; 280(4):H1853-60. PubMed ID: 11247801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of the renin-angiotensin pathway through enzyme inhibition and specific receptor blockade in pacing-induced heart failure: II. Effects on myocyte contractile processes.
    Spinale FG; Mukherjee R; Iannini JP; Whitebread S; Hebbar L; Clair MJ; Melton DM; Cox MH; Thomas PB; de Gasparo M
    Circulation; 1997 Oct; 96(7):2397-406. PubMed ID: 9337216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin AT1 receptor inhibition in pacing induced heart failure: effects on left ventricular myocardial collagen content and composition.
    Clair MJ; Krombach RS; Coker ML; Heslin TL; Kribbs SB; de Gasparo M; Spinale FG
    J Mol Cell Cardiol; 1998 Nov; 30(11):2355-64. PubMed ID: 9925371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of atrial natriuretic peptide on left ventricular performance in conscious dogs before and after pacing-induced heart failure.
    Ohte N; Cheng CP; Suzuki M; Little WC
    J Pharmacol Exp Ther; 1999 Nov; 291(2):589-95. PubMed ID: 10525076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AT1 angiotensin II receptor inhibition in pacing-induced heart failure: effects on left ventricular performance and regional blood flow patterns.
    Clair MJ; Krombach RS; Hendrick JW; Houck WV; Hebbar L; Kribbs SB; Rios G; Whitebread S; Mukherjee R; de Gasparo M; Spinale FG
    J Card Fail; 1998 Dec; 4(4):311-23. PubMed ID: 9924853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin-converting enzyme inhibition and angiotensin II subtype-1 receptor blockade during the progression of left ventricular dysfunction: differential effects on myocyte contractile processes.
    Spinale FG; Holzgrefe HH; Mukherjee R; Webb ML; Hird RB; Cavallo MJ; Powell JR; Koster WH
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1082-94. PubMed ID: 9399980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of the renin-angiotensin pathway through enzyme inhibition and specific receptor blockade in pacing-induced heart failure: I. Effects on left ventricular performance and neurohormonal systems.
    Spinale FG; de Gasparo M; Whitebread S; Hebbar L; Clair MJ; Melton DM; Krombach RS; Mukherjee R; Iannini JP; O SJ
    Circulation; 1997 Oct; 96(7):2385-96. PubMed ID: 9337215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Negative and selective effects of propofol on isolated swine myocyte contractile function in pacing-induced congestive heart failure.
    Hebbar L; Dorman BH; Clair MJ; Roy RC; Spinale FG
    Anesthesiology; 1997 Mar; 86(3):649-59. PubMed ID: 9066332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of angiotensin-(1-12)-caused positive modulation on left ventricular contractile performance in heart failure: Assessment by pressure-volume analysis.
    Li T; Zhang Z; Zhang X; Chen Z; Cheng HJ; Ahmad S; Ferrario CM; Cheng CP
    Int J Cardiol; 2020 Feb; 301():135-141. PubMed ID: 31521437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct effects of chronic beta-adrenergic receptor blockade on left ventricular and myocyte function in a model of tachycardia-induced congestive heart failure.
    Spinale FG; Johnson WS; Wang Y; Wang Z; Mukherjee R; Hebbar L; Jones BU
    J Card Fail; 1996 Dec; 2(4):311-8. PubMed ID: 8989646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular basis of angiotensin-(1-7)-induced augmentation of left ventricular functional performance in heart failure.
    Zhang X; Cheng HJ; Zhou P; Kitzman DW; Ferrario CM; Li WM; Cheng CP
    Int J Cardiol; 2017 Jun; 236():405-412. PubMed ID: 28096047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of altered patterns of left ventricular filling during the development of congestive heart failure.
    Ohno M; Cheng CP; Little WC
    Circulation; 1994 May; 89(5):2241-50. PubMed ID: 8181149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous beta3-adrenoreceptor activation contributes to left ventricular and cardiomyocyte dysfunction in heart failure.
    Morimoto A; Hasegawa H; Cheng HJ; Little WC; Cheng CP
    Am J Physiol Heart Circ Physiol; 2004 Jun; 286(6):H2425-33. PubMed ID: 14962832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cardiac effects of pimobendan (but not amrinone) are preserved at rest and during exercise in conscious dogs with pacing-induced heart failure.
    Ohte N; Cheng CP; Suzuki M; Little WC
    J Pharmacol Exp Ther; 1997 Jul; 282(1):23-31. PubMed ID: 9223536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of functional beta(3)-adrenergic receptor in the failing canine myocardium.
    Cheng HJ; Zhang ZS; Onishi K; Ukai T; Sane DC; Cheng CP
    Circ Res; 2001 Sep; 89(7):599-606. PubMed ID: 11577025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous endothelin-1 depresses left ventricular systolic and diastolic performance in congestive heart failure.
    Onishi K; Ohno M; Little WC; Cheng CP
    J Pharmacol Exp Ther; 1999 Mar; 288(3):1214-22. PubMed ID: 10027861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective vasopressin, angiotensin II, or dual receptor blockade with developing congestive heart failure.
    Clair MJ; King MK; Goldberg AT; Hendrick JW; Nisato R; Gay DM; Morrison AE; McElmurray JH; Krombach RS; Bond BR; Cazaubon C; Nisato D; Spinale FG
    J Pharmacol Exp Ther; 2000 Jun; 293(3):852-60. PubMed ID: 10869385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of heart failure on the mechanism of exercise-induced augmentation of mitral valve flow.
    Cheng CP; Noda T; Nozawa T; Little WC
    Circ Res; 1993 Apr; 72(4):795-806. PubMed ID: 8095187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.